The page describes genomic data as a secure digital asset users can control, share, earn from, or revoke access to. It reports 7,000+ GenoVaults on Story Protocol.
GenoBank expands its onchain genomic data infrastructure on the Story blockchain. The company integrates decentralized storage solutions for genomic datasets, enabling verifiable, immutable records. This move aligns with growing demand for secure genomic data management in research and healthcare sectors.
GenoBank.io, part of the Story ecosystem, is expanding its BioIP platform to register genomic data as tradable digital assets. The platform now supports over 7,000 genomic accounts, 150 research partnerships, and $6.9 million in tokenized BioIP value. This move aims to enable secure, AI-driven access and monetization of genomic data within the growing $85 billion genomics market.
GenoBank.io combines World ID’s 15 million verified users with its Biowallet to enable decentralized ownership of biosamples and genomic data. Users can license data for research revenue, recover lost credentials via DNA verification, and pass tokenized assets to heirs. The integration leverages World ID’s proof-of-personhood verification on GenoBank.io’s existing decentralized lab infrastructure.
